1 – 33 of 33
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings
(
- Contribution to journal › Article
-
Mark
Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
(
- Contribution to journal › Article
- 2020
-
Mark
Individual perspectives on outcomes in Diabetes
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
New Diabetes Questionnaire to add patients' perspectives to diabetes care for adults with type 1 and type 2 diabetes : nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables
(
- Contribution to journal › Article
- 2019
-
Mark
Can people afford to pay for health care? : New evidence on financial protection in Sweden
2019)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Quality of life in chronic conditions using patient-reported measures and biomarkers : a DEA analysis in type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Patient-reported outcome and experience measures for diabetes : development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden
(
- Contribution to journal › Article
-
Mark
Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes - A nationwide cross-sectional study
(
- Contribution to journal › Article
- 2018
-
Mark
A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register : Development and evaluation of content validity, face validity, and test-retest reliability
(
- Contribution to journal › Article
- 2017
-
Mark
Prediction models for exacerbations in different COPD patient populations : Comparing results of five large data sources
(
- Contribution to journal › Article
- 2016
-
Mark
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden
(
- Contribution to journal › Article
-
Mark
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease : Are Current Models Suitable to Evaluate Personalized Medicine?
(
- Contribution to journal › Article
- 2015
-
Mark
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden.
(
- Contribution to journal › Article
-
Mark
Cost-Effectiveness and Heterogeneity: Using Finite Mixtures of Disease Activity Models to Identify and Analyze Phenotypes
2015) In Working Paper / Department of Economics, School of Economics and Management, Lund University(
- Working paper/Preprint › Working paper
- 2014
-
Mark
Costs and quality of life in multiple sclerosis patients with spasticity.
(
- Contribution to journal › Article
-
Mark
Obesity and Surgical Treatment - A Cost-Effectiveness Assessment for Sweden
(
- Contribution to journal › Article
-
Mark
Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden
(
- Contribution to journal › Article
-
Mark
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios
(
- Contribution to journal › Article
- 2012
-
Mark
Budget impact analysis of surgical treatment for obesity in sweden.
(
- Contribution to journal › Article
-
Mark
Drug and treatment costs in Parkinson's disease patients in Sweden.
(
- Contribution to journal › Article
- 2010
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
- 2009
-
Mark
A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.
(
- Contribution to journal › Article
- 2008
-
Mark
The Swedish cost burden of overweight and obesity - Evaluated with the PAR approach and a statistical modelling approach
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
(
- Contribution to journal › Article
- 2007
-
Mark
Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden
(
- Contribution to journal › Article
-
Mark
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades : A population-based study from Copenhagen, Denmark
(
- Contribution to journal › Article
- 2006
-
Mark
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
(
- Contribution to journal › Article
- 2005
-
Mark
Obesity, survival, and hospital costs-findings from a screening project in sweden.
(
- Contribution to journal › Article
-
Mark
Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response.
(
- Contribution to journal › Article
-
Mark
Cost differences for COPD with and without physician-diagnosis
(
- Contribution to journal › Article
- 2004
-
Mark
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease
(
- Contribution to journal › Article
- 2002
-
Mark
Costs of COPD in Sweden according to disease severity
(
- Contribution to journal › Article